People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · AI / ML, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tanium Inc. | — | AI / ML | Series D+ | $911.8M | $5.8B | 2009 |
| Olema Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $527.4M | $2.4B | 2018 |
Andrei Manoliu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrei Manoliu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ben Horowitz | 1 | 15 |
| Bryan Taylor | 1 | 9 |
| MARK FIELDS | 1 | 8 |
| Frank McCormick | 1 | 7 |
| Ian Clark | 1 | 5 |
| David R. Lee | 1 | 5 |
| Eric Brown | 1 | 5 |
| Mary Agnes Wilderotter | 1 | 3 |
| Cynthia Butitta | 1 | 3 |
| Steven Sinofsky | 1 | 3 |
| Marina Bozilenko | 1 | 3 |
| Gorjan Hrustanovic | 1 | 3 |
| Jonathan Chadwick | 1 | 3 |
| Cyrus Harmon | 1 | 2 |
| Sean Bohen | 1 | 2 |
| Michael Carpenter | 1 | 2 |
| Graham Walmsley | 1 | 2 |
| David Myles | 1 | 2 |
| Andrew Rappaport | 1 | 2 |
| Lawrence Fritz | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.